Published in Clin Infect Dis on January 01, 2009
Public health and international drug policy. Lancet (2016) 1.71
Dose-response association between salivary cotinine levels and Mycobacterium tuberculosis infection. Int J Tuberc Lung Dis (2013) 1.44
Factors associated with recurrent tuberculosis more than 12 months after treatment completion. Int J Tuberc Lung Dis (2016) 1.44
Tuberculosis outbreak investigations in the United States, 2002-2008. Emerg Infect Dis (2011) 1.33
Factors that influence current tuberculosis epidemiology. Eur Spine J (2012) 1.30
Tuberculosis transmission and use of methamphetamines in Snohomish County, WA, 1991-2006. Am J Public Health (2010) 1.24
Mortality and HIV transmission among male Vietnamese injection drug users. Addiction (2010) 1.22
Limited utility of name-based tuberculosis contact investigations among persons using illicit drugs: results of an outbreak investigation. J Urban Health (2009) 1.22
Latent tuberculosis among persons at risk for infection with HIV, Tijuana, Mexico. Emerg Infect Dis (2010) 1.07
Self-administered tuberculosis treatment outcomes in a tribal population on the indo-myanmar border, Nagaland, India. PLoS One (2014) 1.07
The diagnostic performance of a single GeneXpert MTB/RIF assay in an intensified tuberculosis case finding survey among HIV-infected prisoners in Malaysia. PLoS One (2013) 1.06
Whole-genome sequencing in outbreak analysis. Clin Microbiol Rev (2015) 1.03
Managing tuberculosis in people who use and inject illicit drugs. Bull World Health Organ (2013) 1.00
Health and oral health care needs and health care-seeking behavior among homeless injection drug users in San Francisco. J Urban Health (2010) 0.96
Latent tuberculosis infection in a Malaysian prison: implications for a comprehensive integrated control program in prisons. BMC Public Health (2014) 0.87
Impact of a methadone maintenance therapy pilot in Vietnam and its role in a scaled-up response. Harm Reduct J (2015) 0.85
Incidence and risk factors for tuberculosis in people living with HIV: cohort from HIV referral health centers in Recife, Brazil. PLoS One (2013) 0.83
Responding to the public health consequences of the Ukraine crisis: an opportunity for global health diplomacy. J Int AIDS Soc (2015) 0.83
Tuberculosis screening in a novel substance abuse treatment center in Malaysia: implications for a comprehensive approach for integrated care. J Subst Abuse Treat (2013) 0.83
High prevalence of HIV, HCV and tuberculosis and associated risk behaviours among new entrants of methadone maintenance treatment clinics in Guangdong Province, China. PLoS One (2013) 0.83
Confronting the HIV, Tuberculosis, Addiction, and Incarceration Syndemic in Southeast Asia: Lessons Learned from Malaysia. J Neuroimmune Pharmacol (2016) 0.80
Risk factors for vitamin D deficiency among HIV-infected and uninfected injection drug users. PLoS One (2014) 0.77
Sex-specific disease outcomes of HIV-positive and HIV-negative drug users admitted to an opioid substitution therapy program in Spain: a cohort study. BMC Infect Dis (2014) 0.77
Risk factors for tuberculosis in foreign-born people (FBP) in Italy: a systematic review and meta-analysis. PLoS One (2014) 0.76
Associated factors for treatment delay in pulmonary tuberculosis in HIV-infected individuals: a nested case-control study. BMC Infect Dis (2012) 0.76
Optimising health and safety of people who inject drugs during transition from acute to outpatient care: narrative review with clinical checklist. Postgrad Med J (2016) 0.75
Optimising plasma levels of clozapine during metabolic interactions: a review and case report with adjunct rifampicin treatment. BMC Psychiatry (2015) 0.75
Can social history variables predict prison inmates' risk for latent tuberculosis infection? Tuberc Res Treat (2012) 0.75
The oral health of heroin drug users: case study in Bosnia and Herzegovina. BMC Public Health (2013) 0.75
Active and latent tuberculosis among HIV-positive injecting drug users in Indonesia. J Int AIDS Soc (2015) 0.75
First Evaluation of GenoType MTBDRplus 2.0 Performed Directly on Respiratory Specimens in Central America. J Clin Microbiol (2016) 0.75
The societal cost of heroin use disorder in the United States. PLoS One (2017) 0.75
Regional Differences in the Prevalence of Major Opportunistic Infections among Antiretroviral-Naïve Human Immunodeficiency Virus Patients in Japan, Northern Thailand, Northern Vietnam, and the Philippines. Am J Trop Med Hyg (2017) 0.75
Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med (1994) 13.11
A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med (1989) 10.98
Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS (1997) 9.08
Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med (2007) 8.81
A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration. N Engl J Med (1997) 8.43
Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep (2000) 7.61
Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep (2005) 6.45
Anti-tuberculous therapy and acute liver failure. Lancet (1995) 6.27
Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. Clin Infect Dis (2005) 5.20
Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users. JAMA (1992) 3.81
Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev (2000) 3.07
Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment. Chest (1997) 3.07
Delayed tuberculosis diagnosis and tuberculosis transmission. Int J Tuberc Lung Dis (2006) 2.97
The use of legal action in New York City to ensure treatment of tuberculosis. N Engl J Med (1999) 2.96
Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev (2004) 2.95
A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS. N Engl J Med (1997) 2.84
Toxic hepatitis with isoniazid and rifampin. A meta-analysis. Chest (1991) 2.79
Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control. Chest (2006) 2.70
HIV infection associated with drug injecting in the newly independent states, eastern Europe: the social and economic context of epidemics. Addiction (1999) 2.67
Drug dependence, a possible new risk factor for tuberculosis disease. Arch Intern Med (1979) 2.57
Differences in contributing factors to tuberculosis incidence in U.S. -born and foreign-born persons. Am J Respir Crit Care Med (1998) 2.52
Transmission of tuberculosis from smear negative patients: a molecular epidemiology study. Thorax (2004) 2.34
Widespread dissemination of a drug-susceptible strain of Mycobacterium tuberculosis. J Infect Dis (1997) 2.31
Tuberculosis in London: the importance of homelessness, problem drug use and prison. Thorax (2007) 2.27
Directly observed therapy in an inner city hospital. Int J Tuberc Lung Dis (1998) 2.25
Nonadherence in tuberculosis treatment: predictors and consequences in New York City. Am J Med (1997) 2.18
Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev (2006) 2.18
Tuberculosis, AIDS, and death among substance abusers on welfare in New York City. N Engl J Med (1996) 2.17
A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users. Am J Med (2001) 2.15
Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance. Bull World Health Organ (2007) 2.09
Medical and psychosocial services in drug abuse treatment: do stronger linkages promote client utilization? Health Serv Res (2000) 1.99
Impact of mobile radiographic screening on tuberculosis among drug users and homeless persons. Am J Respir Crit Care Med (2007) 1.93
Tuberculosis prophylaxis in the homeless. A trial to improve adherence to referral. Arch Intern Med (1996) 1.92
Risk factors associated with default from multidrug-resistant tuberculosis treatment, South Africa, 1999-2001. Int J Tuberc Lung Dis (2006) 1.86
Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus. Am J Respir Crit Care Med (1998) 1.85
Opiate therapy in chronic cough. Am J Respir Crit Care Med (2006) 1.81
Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis (2005) 1.80
Time to detection of Mycobacterium tuberculosis in sputum culture correlates with outcome in patients receiving treatment for pulmonary tuberculosis. Chest (1998) 1.79
Microbial infections, immunomodulation, and drugs of abuse. Clin Microbiol Rev (2003) 1.71
Rifampin-induced methadone withdrawal. N Engl J Med (1976) 1.70
Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group. Ann Intern Med (1993) 1.70
Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group. Ann Intern Med (1997) 1.70
Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med (1993) 1.69
Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. Int J Drug Policy (2007) 1.65
The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations. Clin Infect Dis (2005) 1.62
Methadone maintenance and tuberculosis treatment. BMJ (1996) 1.61
High AIDS awareness may cause tuberculosis patient delay: results from an HIV epidemic area, Thailand. AIDS (2000) 1.61
Hepatitis C virus infection and hepatotoxicity during antituberculosis chemotherapy. Chest (2007) 1.60
The influence of intravenous drug use and HIV infection in the transmission of tuberculosis. AIDS (1996) 1.60
Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease. Arch Intern Med (1996) 1.59
Tuberculosis screening and compliance with return for skin test reading among active drug users. Am J Public Health (1998) 1.56
Comparison of a tuberculin interferon-gamma assay with the tuberculin skin test in high-risk adults: effect of human immunodeficiency virus infection. J Infect Dis (1997) 1.54
Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention. MMWR Recomm Rep (1998) 1.54
Modeling the epidemiology and economics of directly observed therapy in Baltimore. Int J Tuberc Lung Dis (2000) 1.52
Clinical and epidemiological aspects of smoking and tuberculosis: a study of 13,038 cases. Int J Tuberc Lung Dis (2005) 1.49
Lack of association of induration size with HIV infection among drug users reacting to tuberculin. Am J Respir Crit Care Med (1996) 1.47
A cluster of tuberculosis associated with use of a marijuana water pipe. Int J Tuberc Lung Dis (2003) 1.47
Adherence to isoniazid prophylaxis in the homeless: a randomized controlled trial. Arch Intern Med (2000) 1.44
[Incidence and risk factors of the association of AIDS and tuberculosis in Spain]. Med Clin (Barc) (1998) 1.40
A network-informed approach to investigating a tuberculosis outbreak: implications for enhancing contact investigations. Int J Tuberc Lung Dis (2003) 1.38
Outcome of pulmonary tuberculosis treatment in the tertiary care setting--Toronto 1992/93. Tuberculosis Treatment Completion Study Group. CMAJ (1999) 1.37
A cluster of tuberculosis among crack house contacts in San Mateo County, California. Am J Public Health (1994) 1.35
From contact investigation to tuberculosis screening of drug addicts and homeless persons in Rotterdam. Eur J Public Health (2005) 1.33
Comprehensive tuberculosis control for patients at high risk for noncompliance. Am J Respir Crit Care Med (1995) 1.31
Implications of directly observed therapy in tuberculosis control measures among IDUs. Public Health Rep (1994) 1.30
Tuberculosis, HIV seroprevalence and intravenous drug abuse in prisoners. Eur Respir J (2005) 1.30
Incentives vs outreach workers for latent tuberculosis treatment in drug users. Am J Prev Med (2001) 1.30
Tuberculosis in drug users. Clin Infect Dis (1995) 1.30
Tuberculosis outbreak in marijuana users, Seattle, Washington, 2004. Emerg Infect Dis (2006) 1.29
A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users. Drug Alcohol Depend (2002) 1.28
Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study. J Infect Dis (2006) 1.28
[Recent transmission of tuberculosis in Madrid (Spain): usefulness of molecular techniques]. Med Clin (Barc) (2000) 1.21
Tuberculin skin testing in patients with HIV infection: limited benefit of reduced cutoff values. Clin Infect Dis (2006) 1.21
Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk community. J Urban Health (1999) 1.19
Prevention of infectious disease transmission in correctional settings: a review. Public Health (2005) 1.19
Characteristics of tuberculosis patients who generate secondary cases. Int J Tuberc Lung Dis (1997) 1.19
Monetary versus nonmonetary incentives for TB skin test reading among drug users. Am J Prev Med (1999) 1.18
Risk factors for mortality among adult patients with newly diagnosed tuberculosis in Samara, Russia. Int J Tuberc Lung Dis (2006) 1.16
Risk behaviors, HIV seropositivity, and tuberculosis infection in injecting drug users who operate shooting galleries in Puerto Rico. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.16
A multi-state outbreak of tuberculosis among members of a highly mobile social network: implications for tuberculosis elimination. Int J Tuberc Lung Dis (2000) 1.16
Crack cocaine use and other risk factors for tuberculin positivity in drug users. Clin Infect Dis (2002) 1.14
Prevalence and risk factors for positive tuberculin skin tests among active drug users at a syringe exchange program. Int J Tuberc Lung Dis (2000) 1.14
Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis. Clin Infect Dis (2001) 1.13
Predictors of clustering of tuberculosis in Greater Vancouver: a molecular epidemiologic study. CMAJ (2002) 1.12
A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival. Clin Infect Dis (1997) 1.11
Evaluation of a directly observed six months fully intermittent treatment regimen for tuberculosis in patients suspected of poor compliance. Thorax (1996) 1.10
Risk factors for and knowledge of Mycobacterium tuberculosis infection among drug users in substance abuse treatment. Addiction (1998) 1.10
Predictors of adherence to tuberculosis treatment in a supervised therapy programme for prisoners before and after release. Study Group of Adherence to Tuberculosis Treatment of Prisoners. Eur Respir J (1998) 1.09
Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART. AIDS (2007) 1.08
Successful supervised ambulatory management of tuberculosis treatment failures. Ann Intern Med (1982) 1.08
HIV and tuberculosis in Ho Chi Minh City, Vietnam, 1997-2002. Emerg Infect Dis (2007) 1.08
Autopsy findings in a human immunodeficiency virus-infected population over 2 decades: influences of gender, ethnicity, risk factors, and time. Arch Pathol Lab Med (2002) 1.08
Isoniazid hepatotoxicity among drug users: the role of hepatitis C. Clin Infect Dis (2003) 1.06
Yield of tuberculin screening among injection drug users. Int J Tuberc Lung Dis (2004) 1.06
AIDS-defining opportunistic illnesses in the HAART era in New York City. AIDS Care (2007) 1.05
Trends in AIDS-related opportunistic infections among men who have sex with men and among injecting drug users, 1991-1996. J Infect Dis (1998) 1.05
Tuberculosis in the homeless. Arch Fam Med (1995) 1.04
The clinical pharmacokinetics of rifabutin. Clin Infect Dis (1996) 1.04
Characteristics of injection drug users who utilize tuberculosis services at sites of the Baltimore city needle exchange program. J Urban Health (2002) 1.02
Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial. Lancet (2012) 7.01
Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol (2002) 4.20
Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol (2003) 3.29
Evaluation of an HIV nucleic acid testing program with automated Internet and voicemail systems to deliver results. Ann Intern Med (2010) 2.69
Developing an HIV behavioral surveillance system for injecting drug users: the National HIV Behavioral Surveillance System. Public Health Rep (2007) 2.69
Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. J Urban Health (2006) 2.42
Ethical and regulatory considerations in HIV prevention studies employing respondent-driven sampling. Int J Drug Policy (2008) 2.15
Hepatitis C virus transmission from an anesthesiologist to a patient. Arch Intern Med (2002) 2.11
Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Rep (2007) 2.04
Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review. PLoS One (2012) 1.93
Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004. Clin Infect Dis (2008) 1.86
Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users? Epidemiology (2002) 1.83
Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations. J Clin Microbiol (2013) 1.66
Screening for depressive symptoms among HCV-infected injection drug users: examination of the utility of the CES-D and the Beck Depression Inventory. J Urban Health (2004) 1.62
HIV prevalence, risk behaviors, and high-risk sexual and injection networks among young women injectors who have sex with women. Am J Public Health (2003) 1.55
Perceived risk, peer influences, and injection partner type predict receptive syringe sharing among young adult injection drug users in five U.S. cities. Drug Alcohol Depend (2007) 1.50
Cross-border paid plasma donation among injection drug users in two Mexico-U.S. border cities. Int J Drug Policy (2009) 1.45
Pyrosequencing for rapid detection of extensively drug-resistant Mycobacterium tuberculosis in clinical isolates and clinical specimens. J Clin Microbiol (2013) 1.43
Mortality risk among recent-onset injection drug users in five U.S. cities. Subst Use Misuse (2008) 1.39
Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S. Salud Publica Mex (2007) 1.38
Prevalence and correlates of chlamydia trachomatis, neisseria gonorrhoeae, trichomonas vaginalis infections, and bacterial vaginosis among a cohort of young injection drug users in Baltimore, Maryland. Sex Transm Dis (2005) 1.34
Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities. Drug Alcohol Depend (2007) 1.31
Housing status and associated differences in HIV risk behaviors among young injection drug users (IDUs). AIDS Behav (2007) 1.31
Problematic use of prescription-type opioids prior to heroin use among young heroin injectors. Subst Abuse Rehabil (2011) 1.30
The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004. Prev Med (2009) 1.23
Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities. Clin Infect Dis (2006) 1.23
Evaluating the impact of Mexico's drug policy reforms on people who inject drugs in Tijuana, B.C., Mexico, and San Diego, CA, United States: a binational mixed methods research agenda. Harm Reduct J (2014) 1.22
Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004. J Urban Health (2007) 1.21
Distributive syringe sharing among young adult injection drug users in five U.S. cities. Drug Alcohol Depend (2007) 1.21
Association between injection practices and duration of injection among recently initiated injection drug users. Drug Alcohol Depend (2004) 1.17
High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities. Drug Alcohol Depend (2005) 1.17
Prevalence and treatment of latent tuberculosis infection among newly arrived refugees in San Diego County, January 2010-October 2012. Am J Public Health (2014) 1.15
A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C. Am J Public Health (2008) 1.13
Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus. J Infect Dis (2011) 1.13
Pharmacy participation in non-prescription syringe sales in Los Angeles and San Francisco counties, 2007. J Urban Health (2010) 1.13
Healthcare barriers of refugees post-resettlement. J Community Health (2009) 1.12
Young adult injection drug users in the United States continue to practice HIV risk behaviors. Drug Alcohol Depend (2009) 1.12
Predictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention. J Hepatol (2010) 1.10
Latent tuberculosis among persons at risk for infection with HIV, Tijuana, Mexico. Emerg Infect Dis (2010) 1.07
Differences in sexual risk behaviors among male and female HIV-seronegative heterosexual methamphetamine users. Am J Drug Alcohol Abuse (2009) 1.06
Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health-care access among hepatitis C virus positive injection drug users: the Study to Reduce Intravenous Exposures (STRIVE). J Urban Health (2007) 1.06
Prevalence and correlates of crack-cocaine injection among young injection drug users in the United States, 1997-1999. Drug Alcohol Depend (2005) 1.06
Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users. Drug Alcohol Depend (2007) 1.05
Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users. J Urban Health (2010) 1.03
Increasing syringe access and HIV prevention in California: findings from a survey of local health jurisdiction key personnel. J Urban Health (2007) 1.02
Binge use and sex and drug use behaviors among HIV(-), heterosexual methamphetamine users in San Diego. Subst Use Misuse (2010) 1.02
High-risk behaviors associated with injection drug use among recently HIV-infected men who have sex with men in San Diego, CA. AIDS Behav (2011) 1.00
Correlates of attempted suicide among young injection drug users in a multi-site cohort. Drug Alcohol Depend (2004) 0.99
The use of needle exchange by young injection drug users. J Acquir Immune Defic Syndr (2003) 0.97
Border crossing to inject drugs in Mexico among injection drug users in San Diego, California. J Immigr Minor Health (2012) 0.97
Increased drug use and STI risk with injection drug use among HIV-seronegative heterosexual methamphetamine users. J Psychoactive Drugs (2010) 0.96
Injecting alone among young adult IDUs in five US cities: evidence of low rates of injection risk behavior. Drug Alcohol Depend (2007) 0.96
HIV-tuberculosis coinfection in Southern California: evaluating disparities in disease burden. Am J Public Health (2010) 0.94
Ethical considerations in surveys employing respondent-driven sampling. Am J Public Health (2010) 0.94
Development, description, and acceptability of a small-group, behavioral intervention to prevent HIV and hepatitis C virus infections among young adult injection drug users. Drug Alcohol Depend (2007) 0.94
Patterns of drug use, risky behavior, and health status among persons who inject drugs living in San Diego, California: a latent class analysis. Subst Use Misuse (2014) 0.92
Monitoring Therapy Compliance of Tuberculosis Patients by using Video-Enabled Electronic Devices. Emerg Infect Dis (2016) 0.92
Influences of cross-border mobility on tuberculosis diagnoses and treatment interruption among injection drug users in Tijuana, Mexico. Am J Public Health (2009) 0.92
Tracing the origins of Mycobacterium bovis tuberculosis in humans in the USA to cattle in Mexico using spoligotyping. Int J Infect Dis (2010) 0.91
Changes in the sharing of drug injection equipment among street-recruited injection drug users in Chicago, Illinois, 1994--1996. Subst Use Misuse (2005) 0.89
The effect of intimate partner violence on receptive syringe sharing among young female injection drug users: an analysis of mediation effects. AIDS Behav (2007) 0.88
Predictors and correlates of reduced frequency or cessation of injection drug use during a randomized HIV prevention intervention trial. Addiction (2010) 0.87
Trends in mortality of tuberculosis patients in the United States: the long-term perspective. Ann Epidemiol (2011) 0.84
Hepatitis E virus among persons who inject drugs, San Diego, California, USA, 2009-2010. Emerg Infect Dis (2013) 0.83
HIV prevalence and sexual risk behaviour among non-injection drug users in Tijuana, Mexico. Glob Public Health (2011) 0.83
Wild African elephants (Loxodonta africana) discriminate between familiar and unfamiliar conspecific seismic alarm calls. J Acoust Soc Am (2007) 0.82
Evaluating a statewide pilot syringe access program for injection drug users through pharmacies in California. J Urban Health (2010) 0.82
The social and environmental context of cross-border drug use in Mexico: findings from a mixed methods study of young injection drug users living in San Diego, CA. J Ethn Subst Abuse (2012) 0.82
Multidrug-resistant tuberculosis among patients in Baja California, Mexico, and Hispanic patients in California. Am J Public Health (2013) 0.81
Feasibility and acceptability of cell phone diaries to measure HIV risk behavior among female sex workers. AIDS Behav (2014) 0.81
Prevalence of diabetes and metabolic syndrome in a migrant Mixtec population, Baja California, Mexico. J Immigr Minor Health (2013) 0.79
Cigarette-Smoking Intensity and Interferon-Gamma Release Assay Conversion among Persons Who Inject Drugs: A Cohort Study. Pulm Med (2012) 0.79
Individual and socio-environmental factors associated with unsafe injection practices among young adult injection drug users in San Diego. AIDS Behav (2015) 0.78
Peer-education intervention to reduce injection risk behaviors benefits high-risk young injection drug users: a latent transition analysis of the CIDUS 3/DUIT study. AIDS Behav (2013) 0.78
Cigarette smoking and quit attempts among injection drug users in Tijuana, Mexico. Nicotine Tob Res (2013) 0.78
Deportation history among HIV-positive Latinos in two US-Mexico border communities. J Immigr Minor Health (2015) 0.78
Drug-scene familiarity and exposure to gang violence among residents in a rural farming community in Baja California, Mexico. Glob Public Health (2012) 0.77
Under- and over-nutrition among refugees in San Diego County, California. J Immigr Minor Health (2011) 0.77
HIV infection risk among injection drug users in a methadone maintenance treatment program, Taipei, Taiwan 2007-2010. Am J Drug Alcohol Abuse (2012) 0.77
Transitions in latent classes of sexual risk behavior among young injection drug users following HIV prevention intervention. AIDS Behav (2014) 0.76
Tuberculosis testing among populations with high HIV risk in Tijuana, Baja California, Mexico. Rev Panam Salud Publica (2012) 0.75
Awareness of HCV infection among persons who inject drugs in San Diego, California. Am J Public Health (2015) 0.75
Concurrency and HIV transmission network characteristics among MSM with recent HIV infection. AIDS (2016) 0.75
Latent Tuberculosis Screening Using Electronic Health Record Data. Emerg Infect Dis (2020) 0.75
Prevalence of cryoglobulinemia in hepatitis C virus (HCV) positive patients with and without human immunodeficiency virus (HIV) coinfection. J Clin Virol (2004) 0.75